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Recently, various biofuels have been synthesized through metabolic engineering approaches to meet the exploding
energy demands. Hydrocarbon biofuels, energy-equivalent to petroleum-based fuels, are identified as promising
replacements for petroleum. Metabolically engineered Saccharomyces cerevisiae capable of synthesize precursors of
medium-chained hydrocarbons is proposed in this study. The hydroperoxide pathway introduced in S. cerevisiae
consisted of lipoxygenase (LOX) and hydroperoxide lyase (HPL) from almond, which catalyzes linoleic acid to
3(Z)-nonenal, the precursor for medium-chained hydrocarbon biofuels. Proteomics study showed that 31 proteins
displayed different expression levels among four functional strains and most of them were related to carbohydrate
metabolism and protein synthesis, suggested prospective capabilities of energy generation and exogenous protein
synthesis. Biotransformation efficiency studies carried out by GC-FID were in accordance with the expectations. The
highest yield of 3(Z)-nonenal was up to 1.21 ± 0.05 mg/L with the carbon recovery of up to 12.4%.
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ProteomicsIntroduction
Recently, petroleum shortage and environmental concerns
have emphasized the synthesis and utilization of renew-
able fuels (Atsumi et al. 2008; Chang and Keasling 2006;
Lennen et al. 2010). Biomass-derived ethanol as drop-in
fuel is currently in use, while hydrocarbons which elimin-
ate the drawbacks of ethanol are also promising biofuels
(Regalbuto 2009).
Hydrocarbons are highly compatible with existing en-
ergy infrastructure due to its chemical resemblance to
traditional petroleum-based fuels. Besides, hydrocarbons
are energy-equivalent to petroleum-based fuels and render
no mileage penalty in the procedure of usage. Moreover,
being immiscible in water eliminate the additional effort
required for water separation and distillation step (Boundy
et al. 2011), further makes hydrocarbons promising diesel
substitutes.
Recent research has identified various genetically-
engineered micro-organisms capable of producing* Correspondence: WNChen@ntu.edu.sg
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in any medium, provided the original work is phydrocarbons (Steen et al. 2010; Rutherford et al. 2010).
Fatty aldehydes derived from lipid biosynthesis were
identified to be metabolically flexible precursors for a
diversity of biofuels, including alkanes, free fatty acids
and wax esters (Kaiser et al. 2013). In this study, we
will therefore explore the biosynthesis capabilities of
medium-chained aldehydes through metabolic engin-
eering approaches.
The aldehyde-producing hydroperoxide pathway in
plants has been studied and the corresponding genetic in-
formation has been elucidated (Mita et al. 2001; Santino
et al. 2005; Tijet et al. 2001; Mita et al. 2005). Hydroperox-
ide pathway starts with hydroperoxidation of polyunsatur-
ated fatty acid, linoleic acid. With LOX catalyzing, one
peroxy is inserted onto the backbone of linoleic acid and
yield one unsaturated acid hydroperoxide (HPOD). HPOD
can subsequently be metabolized via a number of second-
ary reactions while one of them is to be cleaved by HPL
and yield one aldehyde and one oxo-acid (Feussner and
Wasternack 2002). Linoleic acid can be oxygenated either
at carbon atom 9(9LOX) or 13(LOX) of the backbone. In
the case of oxygenating at carbon atom position 9, linoleicn Open Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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nonanoic acid, as shown in Figure 1. 3(Z)-nonenal is
our target medium-chained biofuel precursor in this study.
We used S. cerevisiae to construct whole-cell based cata-
lyst which was capable of synthesize 3(Z)-nonenal through
exogenous expressing of 9LOX and 9HPL from almond
(Prunus dulcis).
It has been reported that, after absorption into S. cerevi-
siae from media, the degradations of long-chained fatty
acids (LCFAs) are confined in peroxisomes (Hiltunen
et al. 2003; Hettema and Tabak 2000). The protein com-
plex, Pxa1p-Pxa2p, which embeds in the peroxisomal
membrane, functions as transporter and translocates acti-
vated fatty acids into peroxisomes for beta-oxidation, util-
izing the energy of ATP hydrolysis. Furthermore, previous
results have confirmed that LCFAs cannot enter peroxi-
somes in Δpxa1 and Δpxa2 mutant and disruption of ei-
ther pxa1 or pxa2 leads to latency of LCFA β-oxidation
while disrupting both genes exhibited similar phenotype
(Hettema et al. 1996).
In this study, exogenous genes 9LOX and 9HPL were
expressed in S. cerevisiae. Apart from wild type as control,
we used Δpxa1, Δpxa2 and Δpxa1&2 mutants as the hosts
to block the translocations of absorbed LCFAs into peroxi-
somes and divert them to the exogenous hydroperoxide
pathway. Proteomics analysis using 2D LC-MS/MS ap-
proaches provided us a global overview of protein expres-
sion levels to determine the potentials of the constructed
whole-cell based catalysts (Wiese 2007). The biotrans-
formation efficiencies of the functional strains were also
characterized by GC-FID approach and the highest yield
of 3(Z)-nonenal we achieved was up to 1.21 mg/L.
Materials and methods
Strains and culture media
E.coli strain Top10 was used for cloning and plasmid
propagation and cultured at 37°C with constant shakingFigure 1 Pathway of medium-chained biofuels precursor synthesis.at 250 rpm. LB broth contained 10 g/L bacto-tryptone
(Fluka), 5 g/L yeast extract and 5 g/L NaCl (Sigma). The
S. cerevisiae strains (Table 1) were cultured at 30°C with
constant shaking at 250 rpm. YPD medium consisted of
10 g/L yeast extract (Fluka), 20 g/L peptone (Bacto) and
20 g/L dextrose (Sigma). YNB-LEU selective media con-
sisted of 6.7 g/L yeast nitrogen base without amino acids
(Sigma), 0.69 g/L DO Supplement-LEU (Clontech) and
20/L dextrose or galactose (Sigma). YNB-HIS selective
media contained 6.7 g/L yeast nitrogen base without
amino acids (Sigma), 0.69 g/L DO Supplement-HIS (Clon-
tech) and 20/L dextrose or galactose (Sigma).
Recombinant plasmid construction
All the oligonucleotide primers in Table 1 were synthesized
by Integrated DNA Technologies. All restriction enzymes
used in this study were purchased from New England Bio-
labs. Ligation reactions were performed using T4 ligase
(Fermentas). PCR reactions were carried out with HotStar-
Taq Plus Master Mix Kit (Qiagen) according to standard
protocols. Gel extractions were carried out using QIAquick
Gel Extraction Kit (Qiagen). E.coli minipreps were per-
formed with QIAprep Spin Miniprep Kit (Qiagen).
Codon optimized genes 9LOX and 9HPL were gener-
ated by Geneart (acc. No. KC920894 and KC920895). The
cloning vector pESC-LEU (Agilent) was adopted, which
contains the GAL1 and GAL10 yeast promoters in oppos-
ing orientations, capable of introducing two genes into
one strain under the control of a repressible promoter.
Primers F-BamHI and R-SalI in Table 1 were used to
introduce BamHI and SalI into 9LOX. Flanked by 5′
BamHI restriction enzyme site and 3′ SalI site, 9LOX
gene was then inserted into pESC plasmid to obtain
9LOX-pESC recombinant plasmid. SacI and NotI restric-
tion endonucleases were adopted to double digest 9HPL
gene from default plasmid pMK-RQ. The DNA fragment
is flanked by 5′ SacI restriction enzyme site and 3′ NotI
site, and inserted into 9LOX-pESC recombinant plasmid
to obtain the recombinant plasmid 9LOX-9HPL-pESC
(9LHP), shown in Additional file 1: Figure AF2.Double deletion strain construction
The pUG plasmid carrying gene disruption cassettes con-
taining HIS5 heterologous marker genes with loxP sites
was selected for gene disruption (Gueldener et al. 2002).
The target genes in S. cerevisiae were pxa1 and pxa2, the
heterodimers of peroxisomal membrane transporter
Pxa1p-Pxa2p. The sequences flanking the target genes
were added to the 5′ end of OL3′ and OL3′ sequences: 40
nucleotide stretches that are homologous to sequences up-
stream of the ATG start codon, and down-stream of the
stop codon of the targeted gene respectively. Primer se-
quences are shown in Table 1.
Table 1 Primers, plasmids and strains used in this work
Name Description Reference
E. coli strain
Top 10 F-mcrA Δ(mrr-hsdRMS-mcrBC) Φ80lacZΔM15 ΔlacX74 recA1 araD139 Δ(ara leu) 7697 galU galKrpsL (StrR) endA1 nupG Life Technology
Primers for gene disruption
Δpxa2-F 5′- ATAATAATAC AATTAAAAGT TACCGAAGAA AGATTTTATA CAGCTGAAGC TTCGTACGC-3′ This work
Δpxa2-R 5′- CAATTTATAC ATGATTTGGA TCCTCCTTTG GCTATGTATG GCATAGGCCA CTAGTGGATC TG-3′ This work
Primers for restriction endonuclease
F-BamHI 5′-CGGGATCCAT GTTGCATAAC TTGTTCGACA AGA-3′ This work
R-SalI 5′-GCGTCGACAG TAGAATCCAA ACCCAACAAT GGA-3′ This work
Plasmids
PUG27 loxP-kanMX-loxP disruption module plasmid EUROSCARF
pESC-leu With GAL1 and GAL10 yeast promoters in opposite orientation, CYC1 and ADH1 terminator respectively Agilent
S. cerevisiae strains
Wild type MATa; his3Δ 1; leu2Δ 0; met15Δ 0; ura3Δ 0 EUROSCARF
Δpxa1 BY4741; Mat a; his3D1; leu2D0; met15D0; ura3D0; YPL147w::kanMX4 EUROSCARF
Δpxa2 BY4741; Mat a; his3D1; leu2D0; met15D0; ura3D0; YKL188c::kanMX4 EUROSCARF
Δpxa1&2 BY4741; Mat a; his3D1; leu2D0; met15D0; ura3D0; YPL147w::kanMX4; YKL188c::his This work
WT-pESC wild type carring pESC This work
Δpxa1-pESC Δpxa1 carrying pESC This work
Δpxa2-pESC Δpxa2 carrying pESC This work
Δpxa1&2-pESC Δpxa1&2 carrying pESC This work
WT-9LHP wild type carring 9LHP This work
Δpxa1-9LHP Δpxa1 carrying 9LHP This work
Δpxa2-9LHP Δpxa2 carrying 9LHP This work
Δpxa1&2-9LHP Δpxa1&2 carrying 9LHP This work
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purchased from EUROSCARF. The Δpxa1 strain was
transformed with the pxa2::his using PEG-LiAc method
(Gietz and Schiestl 2007) to construct double deletion
strain Δpxa1&2.Transformed deletion stains Δpxa1&2
strain were selected via histidin prototroph by growing
on synthetic complete minimal medium deficient in his-
tidine. Yeast colony PCR was carried out to further con-
firm the gene disruption.
Functional strains construction
Recombinant plasmid 9LHP was transformed into S. cer-
evisiae wild type, Δpxa1, Δpxa2 and Δpxa1&2, to obtain
WT-9LHP, Δpxa1-9LHP, Δpxa2-9LHP and Δpxa1&2-
9LHP functional strains. Corresponding controls, WT-
pESC, Δpxa1-pESC, Δpxa2-pESC and Δpxa1&2-pESC
were constructed by transforming empty pESC plasmid
into the four strains (Table 1).
Protein extraction and labeling
The S. cerevisiae functional strains WT-9LHP, Δpxa1-
9LHP, Δpxa2-9LHP and Δpxa1&2-9LHP were cultured at
30°C with constant shaking at 250 rpm using 50mLYPD-LEU selective media containing galactose to induce the
promoter. After 3 days’ culture, S. cerevisiae cells were col-
lected. For cell lysis and protein extraction, all steps were
carried out on ice to avoid denaturation of proteins. Same
amount (OD600 = 20) units of yeast cells were pelleted at
13,000 rpm, 4°C for 5 min. The cell pellets were washed
twice by distilled water and re-suspended in 300 μL of
yeast lysis buffer which consisted of: 8 M Urea, 50 mM
DTT, 50 mM Tris-Cl (pH7.6), 100 mM NaCl, 0.1% Triton
X-100, 1 mM EDTA and 1 mM PMSF. Equal volumes of
acid-washed glass beads were added and the mixtures
were performed in the bead mill by 5 cycles of 30s of vor-
tex at 4.0 m/s with 30s of cooling on ice. Lysates were cen-
trifuged at 10,000 rpm for 10 min at 4°C and supernatants
were collected and stored at −80°C. The protein concen-
trations were determined following the standard protocol
of 2D Quant Kit (GE Healthcare).
A total of 100 μg proteins from functional strains WT-
9LHP, Δpxa1-9LHP, Δpxa2-9LHP and Δpxa1&2-9LHP
were collected and labeled by iTRAQ Reagent Multi-
Plex Kit (AB Sciex) according to the standard protocol
as follows: 20 μL dissolution buffer and 1 μL denaturant
were added to each sample; vortex to mix; 2 μL reducing
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1 h; 1 μL cysteine-blocking reagent was added to each sam-
ple; vortex to mix; incubate 10 min at room temperature;
20 μL of 0.25 μg/μL sequence grade modified trypsin (Pro-
mega, US) was added to each sample to digest the protein
overnight at 37°C; amino-modifying labeling reagent 114,
115, 116 and 117 were used to label four samples respect-
ively: WT-9LHP protein sample was labeled with iTRAQ
tag 114; Δpxa1-9LHP protein protein sample was labeled
with iTRAQ tag 115; Δpxa2-9LHP protein sample was la-
beled with iTRAQ tag 116; Δpxa1&2-9LHP protein sample
was labeled with iTRAQ tag 117. The labeled samples were
then combined together and condensed to roughly 100 μL
using a thermal shaker at 30°C.
LC-MS analysis
The labeled samples were analyzed by online 2D Nano-
LC-MS/MS 1200 series nanoflow liquid chromatography
system (Agilent Technologies) interfaced with 6500 Q-
TOF mass-spectrometer with HPLC-Chip Cube (Agilent
Technologies). The HPLC-Chip was a combination of
Zorbax 300SB C18 reversed-phase column (75 μm×
50 mm, 3.5 μm) packing with Zorbax 300SB C18 enrich-
ment column (0.3 × 5 mm, 5 μm).
In the first dimension, 4 μL of sample was loaded onto
the polysulfoethyl, a strong cation-exchange (SCX) col-
umn (0.32 × 50 mm, 5 μm). The retained peptides were
then eluted by injecting 8 μL ammonium formate solu-
tions in concentration gradient of 20, 40, 60, 80, 100,
200, 500 and 1000 mM. In the second dimension, the ef-
fluent was trapped onto Zorbax 300SB C18 enrichment
column during the enrichment mode by buffer A (5%
acetonitrile and 0.1% formic acid) with a flow rate of
4 μL/min. Then the peptides trapped on enrichment col-
umn were eluted for 60 min by buffer B (0.1% formic acid)
and buffer C (0.1% formic acid + acetonitrile nanoflow
gradient from 5% to 80% in 60 min) at a flow rate of
300 μL/min. Subsequently, the effluent flowed through the
analytical Zorbax 300SB C18 reversed-phase column for
separation with the HPLC-Chip on analytical mode. The
analysis was accomplished by 6500 Q-TOF mass spec-
trometer with a capillary voltage of 1950 V for 10 runs in
total. For MS analysis, positive ionization mode was used.
Survey scans were from m/z 300 to 2000 with an acquisi-
tion rate of 4 spectra per second.
LC-MS/MS data analysis
Peptide quantification and protein identification were per-
formed with Spectrum Mill MS Proteomics Workbench
(Agilent Technologies). Each MS/MS spectrum was
searched for the species of S. cerevisiae against the UniProt-
Swiss-Prot database. Methyl-methane-thiosulfate-labeled
cysteine and iTRAQ modification of free amine in the
amino terminus and lysine were set as fixed modification.Protein relative quantification using iTRAQ was performed
on the MS/MS scans. Protein quantification data with two
or more unique peptides identified with confidence > 99%
and the p value < 0.05 were selective for further statistical
analysis. Three independent batches were performed to in-
crease statistically evidence of protein expression. The over-
lapping isotopic contributions were used to correct the
calculated peak area ratios and to estimate the relative
abundances of a specific peptide.
Biotransformation product detection
Functional strains were cultured in YNB-LEU containing
galactose to induce the promoters. After reaching an
OD600 = 1, 20 mL of the culture was collected and pel-
leted and washed twice with 100 mM potassium phos-
phate buffer at pH = 6.5 to prepare resting cells and then
transferred to 250 mL GL-45 Erlenmeyer flask (Chem-
glass Life Sciences). Biotransformation buffer used was
20 mL potassium phosphate buffer with 100 μL linoleic
acid solution (5% v/v with 0.2% tween-80). The flasks
were sealed with GL-45 open top cap and parafilms
(Chemglass Life Sciences) and incubated at 30°C on an
orbital shaker (250 rpm) for 3 days.
Headspace samples of the cultures were determined by
Agilent 6890 N GC-FID system (Agilent) equipped with Agi-
lent J&W DB-WAX column (30 m× 0.25 mm×0.25 μm,
Agilent). 1 mL SampleLock syringe (Hamilton) was used to
draw out the headspaces of the 20 mL cultures to inject into
GC system. GC settings were: carrier gas: helium; column
flow: 2.0 ml/min; splitless; inject temperature: 230°C The
analyzing temperature program used was: 50-230°C in
18 min; 230°C for 2 min. Product identification was carried
out by comparing with authentic standards and benzoalde-
hyde was used as internal control for quantification.Results
Strains construction
Recombinant plasmid 9LHP (shown in Additional file 1:
Figure AF2) was constructed according to the proced-
ure described in “Materials and methods”. The size of
the recombinant plasmid 9LHP was 11820 bp and gene-
sequencing results proved that no site mutation in the
recombinant plasmid.
We constructed double mutant Δpxa1&2 using PUG27
plasmid carrying lox-his5+-lox. Then recombinant plasmid
9LHP or empty vector pESC was transformed into S. cere-
visiae strains wild type, single mutants Δpxa1-9LHP and
Δpxa2-9LHP and double mutant Δpxa1&2 to obtain func-
tional strains WT-9LHP, Δpxa1-9LHP, Δpxa2-9LHP,
Δpxa1&2-9LHP and control strains WT-pESC, Δpxa1-
pESC, Δpxa2-pESC, Δpxa1&2-pESC. All the functional
strains and control strains grown well on YPD and YNB-
LEU selective minimal media.
Li and Chen AMB Express 2014, 4:61 Page 5 of 9
http://www.amb-express.com/content/4/1/61Proteomic analysis
The proteomic profiling of four functional strains was car-
ried out by On-line 2D LC-MS/MS system (Additional
file 1: Figure AF1). The Spectrum Mill system was used
for peptides identification. Figure 2 and Additional file
1: Figure AF4 showed the representative peptide frag-
mentation spectrum of glucose-6-phosphate isomerase:
(R)AVYHVALR(N). Basing on the analytical conditions,
more than 200 proteins were detected while 31 showed
different levels among the four functional strains, as
shown in Table 2 with WT-9LHP as reference. The
average of protein expression levels in WT-9LHP strain
was taken as 1. The “average of B/A”, “average of C/A”
and “average of D/A” refer to the average ratios of pro-
tein expression levels in Δpxa1-9LHP, Δpxa2-9LHP
and Δpxa1&2-9LHP strains over those in WT-9LHP
strain.
We classified the 31 protein of interest into eight cat-
egories according to their functions: GAL1 and GAL7
from galactose metabolism; HXK1, GI1, PFK2, FBA1,
TPI1, TDH, PGK1, GPM1, ENO and PYK1 from glycoly-
sis; CIT1 and ACO1 from TCA cycle; ATP1 and ATP2
from ATP synthesis; LEU1, LEU2, MET6 and PDC from
amino-acid metabolism; TIF, TEF1, RPL4 and RPL19 from
protein biosynthesis; HSP12, HSP26 from heat shock pro-
tein; POR1, SAM2, YMR226C and SOD1 involved in
other bioprocess.
It is noteworthy that in the Δpxa1&2-9LHP strain, all
the proteins listed showed higher levels than strain WT-
LHP to different extents. The levels of the listed proteins
in strains Δpxa1-9LHP and Δpxa2-9LHP were mostly
equivalent to strain WT-9LHP.
Biotransformation
Functional strains and control strains were cultured in
YNB-LEU selective media with galactose inducing the
promoters of heterologous genes. As the produced 3(Z)-Figure 2 Representative peptide fragmentation spectrum of glucose-
Δpxa1-9LHP, Δpxa2-9LHP and Δpxa1&2-9LHP combined sample.nonenal would be secreted outside and then vaporize into
the headspace for being insoluble in water phase and
volatile, 1 mL of the headspace of the cultures were ex-
tracted and injected into GC-FID for qualification and
quantification.
Preliminary results have shown that, when linoleic acid was
added to cultures of the growing cells, no detectable targeting
volatile compounds was produced (Julsing et al. 2012). Thus
non-growing but metabolically-active resting cells with higher
specific catalyzing activities were obtained in this study.
Functional strains WT-9LHP, Δpxa1-9LHP, Δpxa2-
9LHP, Δpxa1&2-9LHP and corresponding control strains
WT-pESC, Δpxa1-pESC, Δpxa2-pESC, Δpxa1&2-pESC
were cultured, collected and prepared as resting cells for
3 days’ biotransformation. Gas samples of the headspaces
of the cultures were determined with GC-FID system.
In the GC spectra, peaks at 8.82 min were identified as
3(Z)-nonenal (Additional file 1: Figure AF3). The charac-
terizations of catalyzing activities of functional strains
were repeated for 5 times, and the control strains were
repeated for 3 times. Figure 3 showed the 3(Z)-nonenal
production level. All the control strains produced non-
detectable levels of 3(Z)-nonenal. WT-9LHP, Δpxa1-9LHP
and Δpxa2-9LHP strains displayed similar producing cap-
abilities, which were up to 0.57 ± 0.09 mg/L, 0.50 ±
0.07 mg/L and 0.48 ± 0.02 mg/L respectively. While
Δpxa1&2-9LHP produced twofold higher level of 3(Z)-
nonenal, up to 1.21 ± 0.05 mg/L. The catalyzing efficiencies
of the functional strains were also calculated. WT-9LHP,
Δpxa1-9LHP and Δpxa2-9LHP have biotransformed 5.8%,
5.11% and 4.95% of linoleic acid into 3(Z)-nonenal respect-
ively while Δpxa1&2-9LHP performed the highest carbon
recovery rate of up to 12.4% (Table 3).
Discussion
Since the emergence of “metabolic engineering”, the poten-
tials in producing unnatural specialty chemicals through6-phosphate isomerase: (R)AVYHVALR(N) in WT-9LHP,
Table 2 Relative changes in protein expression between S. cerevisiae wild type and engineered strains







GAL1 Galactokinase 9 0.870 ± 0.340 0.587 ± 0.225 3.783 ± 0.215
GAL7 Galactose-1-phosphate uridylyltransferase 2 1.230 ± 0.005 1.387 ± 0.965 1.008 ± 0.021
Glycolysis
HXK1 Hexokinase-1 2 0.723 ± 0.259 0.691 ± 0.104 3.489 ± 0.368
PGI1 Glucose-6-phosphate isomerase 3 1.032 ± 0.460 1.330 ± 0.180 9.891 ± 0.251
PFK2 Phosphofructokinase 3 1.236 ± 0.155 1.149 ± 0.100 1.426 ± 0.197
FBA1 Fructose-biophosphate aldolase 8 1.094 ± 0.155 0.871 ± 0.235 2.304 ± 0.942
TPI1 Triosephosphate isomerase 6 1.123 ± 0.380 0.849 ± 0.070 1.038 ± 0.357
TDH Glyceraldehyde 3-phosphate dehydrogenase 15 1.117 ± 0.305 0.925 ± 0.220 1.664 ± 0.541
PGK1 Phosphoglycerate kinase 19 1.066 ± 0.225 0.798 ± 0.120 1.286 ± 0.076
GPM1 Phosphoglycerate mutase 1 14 1.047 ± 0.210 0.750 ± 0.145 1.500 ± 0.457
ENO Enolase 19 1.185 ± 0.160 0.912 ± 0.155 2.176 ± 0.478
PYK1 Pyruvate kinase 6 1.186 ± 0.200 0.831 ± 0.195 1.831 ± 0.147
TCA cycle
CIT1 Citrate synthase, mitochondrial 3 1.256 ± 0.820 1.982 ± 0.230 5.580 ± 0.248
ACO1 Aconitate hydratase, mitochondrial 3 0.961 ± 0.400 1.033 ± 0.075 1.737 ± 0.128
ATP synthesis
ATP1 ATP synthase subunit alpha, mitochondrial 6 1.222 ± 0.260 1.005 ± 0.030 1.157 ± 0.160
ATP2 ATP synthase subunit beta, mitochondrial 8 1.176 ± 0.040 1.123 ± 0.085 3.216 ± 0.205
Amino-acid metabolism
LEU1 3-isopropylmalate dehydratase 3 0.883 ± 0.075 1.023 ± 0.335 1.424 ± 0.200
LEU2 3-isopropylmalate dehydrogenase 17 3.477 ± 0.630 1.070 ± 0.335 2.570 ± 0.254
MET6 5-methyltetrahydropteroyltriglutamate–homocysteine methyltransferase 10 1.050 ± 0.125 0.881 ± 0.430 2.018 ± 0.121
PDC Pyruvate decarboxylase isozyme 12 1.305 ± 0.355 1.118 ± 0.115 1.894 ± 0.218
Protein biosynthesis
TIF ATP-dependent RNA helicase eIF4A 3 1.408 ± 0.025 0.752 ± 0.295 1.655 ± 0.245
TEF1 Elongation factor 1-alpha 8 0.910 ± 0.375 0.758 ± 0.185 1.507 ± 0.110
RPL4 60s ribosomal protein L4 9 1.245 ± 0.255 0.778 ± 0.035 1.418 ± 0.068
RPL19 60s ribosomal protein L19 2 1.218 ± 0.285 1.114 ± 0.805 2.995 ± 0.197
Heat shock proteins
HSP 12 12 kDa Heat shock protein 2 2.199 ± 0.640 0.882 ± 0.135 2.308 ± 0.219
HSP 26 Heat shock protein 26 3 2.281 ± 0.675 1.823 ± 0.360 2.453 ± 0.195
STI1 Heat shock protein STI1 2 1.363 ± 0.665 0.485 ± 0.035 3.450 ± 0.377
Unknown
POR1 Mitochondrial outer membrane protein porin 1 4 1.033 ± 0.395 0.808 ± 0.445 2.785 ± 0.066
SAM2 S-adenosylmethionine synthetase 2 2 1.271 ± 0.300 0.624 ± 0.085 2.125 ± 0.151
YMR226C Uncharacterized oxidoreductase YMR226C 2 1.856 ± 0.375 1.260 ± 0.110 3.051 ± 0.265
SOD1 Superoxide dismutase [Cu-Zn] 2 6.360 ± 0.420 3.942 ± 1.400 7.910 ± 0.330
Average of protein expression levels in WT-9LHP strain was taken as 1 and the deviation was calculated from three independent LC-MS/MS analysis results. The
“Average of B/A” refers to the average ratio of protein expression level in Δpxa1-9LHP strain over that in WT-9LHP strain. “Average of C/A”refers to the average
ratio of protein expression level in Δpxa2-9LHP strain over that in WT-9LHP strain. The “Average of D/A” refers to the average ratio of protein expression level in
Δpxa1&2-9LHP strain over that in WT-9LHP strain.
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Figure 3 3(Z)-nonenal production levels by functional strains.
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explored, especially for the discovery of petroleum-
replacing biofuels (Keasling 2012). Among various reported
biofuels, hydrocarbons, with high energy density and com-
patibility with current energy storage, transportation and
utilization system, outstood as promising petroleum substi-
tutes. While productions of short-chained (Atsumi et al.
2008; Steen et al. 2008; Santiago-Gomez et al. 2009) and
long-chained hydrocarbons (Schirmer et al. 2010; Blazeck
et al. 2013) have been widely explored, biofuels and precur-
sors in medium-chained range were seldom reported. In
this study, we introduced hydroperoxide pathway to con-
vert linoleic acid to 3(Z)-nonenal, one promising medium-
chained hydrocarbon precursor.
The 2D LC-MS/MS approach was adopted to analyze
the relative protein expression levels among four func-
tional strains, WT-9LHP, Δpxa1-9LHP, Δpxa2-9LHP
and Δpxa1&2-9LHP as shown in Table 2. We classified
the 31 protein of interest into eight categories according
to their functions.
In order to induce the promoters on the recombinant
plasmid, galactose was added to the culture medium as
the sole carbon source. After absorption, galactose would
be converted to glucose-1-phosphate to enter glycolysisTable 3 Production of functional strains and carbon recovery
Functional strains WT-9LHP Δpxa1-
Yield (mg/L) 0.57 ± 0.09 0.50 ± 0
Carbon recovery (%) 5.80 ± 2.01 5.11 ± 1through Leloir pathway. Two proteins, GAL1 and GAL7,
which catalyze the two irreversible steps in Leloir pathway,
showed comparable levels among WT-9LHP strain,
Δpxa1-9LHP strain and Δpxa2-9LHP strain while up-
regulated in Δpxa1&2-9LHP strain.
Glycolysis is the metabolic pathway that converts glu-
cose to pyruvate with the production of two molecules of
ATP. Glycolysis pathway consists of ten enzymes: HXK1,
PGI1, PFK2, FBA1, TPI1, TDH, PGK1, GPM1, ENO and
PYK1. Our results showed that the levels of the ten en-
zymes in Δpxa1-9LHP strain and Δpxa2-9LHP strain were
comparable to WT-9LHP strain. However, the levels of all
the ten proteins were much higher (even 9.891 folds for
PGI1) in Δpxa1&2-9LHP strain which suggested that the
up-regulated activity of glycolysis.
Pyruvate, the end product of glycolysis, can be used in
aerobic respiration via TCA cycle. Pyruvate decarboxylated
by pyruvate dehydrogenase catalyzing was converted into
acetyl-CoA, the starting point of TCA cycle. Our results
showed that, the mitochondrial enzymes CIT1 and ACO1
involved in TCA cycle and the enzymes ATP1 and ATP2
involved in ATP synthesis displayed equivalent or higher
expression levels in Δpxa1-9LHP strain, Δpxa2-9LHP
strain and Δpxa1&2-9LHP strain comparing to WT-9LHP
strain, suggesting the up-regulated activities.
The metabolic pathways mentioned above, galactose
metabolism, glycolysis, TCA cycle an ATP synthesis, are
steps in carbohydrate catabolism which breaks down car-
bohydrates and release energy in the form of ATP. It is
noteworthy that the enzymes involved in these pathways
were most notably up-regulated in the strain Δpxa1&2-
9LHP which suggested the most active metabolism and
energy provision.
With galactose inducing the promoters, exogenous
genes 9LOX and 9LHP carried by high copy number vec-
tor pESC were expressed. In the procedure of synthesis of
unique proteins and peptides, amino acids metabolism
was also important. LC-MS/MS results showed that four
enzymes involved in the amino acid metabolism LEU1,
LEU2, MET6 and PDC, along with four enzymes involved
in protein biosynthesis TIF, TEF1, RPL4 and RPL19 were
also significantly up-regulated in the strain Δpxa1&2-
9LHP. The up-regulations of these enzymes supported the
exogenous genes expression well.
Proteins mentioned above were involved in energy-
generation and protein synthesis. The significant higher
levels in strain Δpxa1&2-9LHP suggested possibly highestrates
9LHP Δpxa2-9LHP Δpxa1&2-9LHP
.07 0.48 ± 0.02 1.21 ± 0.05
.63 4.95 ± 0.41 12.40 ± 0.05
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LHP, Δpxa1-9LHP and Δpxa2-9LHP, the expression level
differences were slighter which suggested comparable bio-
transformation efficiencies. Our expectations would be
tested in subsequent biotransformation studies performed
on the functional strains and control strains.
Furthermore, three heat shock proteins related to
stress response, HSP12, HSP26 and STI1 showed signifi-
cantly different levels among the four functional strain.
The introduction of exogenous genes and the folding of
the proteins may well be stress to the yeast cells and the
up-regulations of these proteins were to keep the bal-
ance of the intracellular metabolism. In addition, the
levels of POR1, SAM2, YMR226C and SOD1 were also
found different among the four functional strain which
remained to be studied. The mechanism details of the
above 31 proteins level differences however still need to
be further investigated.
While resting cells showed good biotransformation ac-
tivities, growing cells did not produce detectable amount
of 3(Z)-nonenal. Possible explanation is that growing
cells were more active in cell divisions rather than per-
forming catalyzing reactions. Furthermore, with the
presence of galactose in the culture, which is the pre-
ferred carbon source, growing cells would less likely to
take linoleic acid from the medium.
In this study, single deletion strains displayed compar-
able biotransformation efficiency as the wild type strain,
as shown in Figure 3. The significantly higher biotrans-
formation efficiency of functional strain Δpxa1&2-9LHP
indicates that the combination of the two mutations
would influence the flux of absorbed linoleic and further
retain the absorbed linoleic acid in cytosol to be de-
graded through the introduced hydroperoxide pathway.
As in the biotransformation cultures, linoleic acid was
the sole carbon source. Certain flux ratio would be
degraded and generate energy to support the living
activities of the cells apart from as substrate for 3(Z)-
nonenal biotransformation,. Functional strains WT-9LHP,
Δpxa1-9LHP and Δpxa2-9LHP performed equivalent bio-
transformation efficiencies, while Δpxa1&2-9LHP strain
showed two-fold higher biotransformation with an effi-
ciency of up to 12.1%. This biotransformation results were
consistent with our expectations from the proteomics ana-
lysis results.
In conclusion, we have demonstrated a yeast-based
whole-cell biocatalyst capable of transforming polyunsat-
urated fatty acids into medium-chained aldehyde, the
medium-chained biofuel precursor. The comparative pro-
teomics analysis offered an approach to study the overall
protein in the cells and potentials as catalyst. This study
lay foundation in our future direction to synthesize
medium-chained hydrocarbons through metabolic engin-
eering approaches.Additional file
Additional file 1: Figure AF1. Total intensity chromatogram results of
peptides eluted by gradient concentrations of ammonium formate.
Figure AF2 Scheme of recombinant plasmid 9LHP. Figure AF3 GC-FID
spectra of biotransformation detection: retention time at 8.82 min was
identified as 3(Z)-nonenal. Blue:3(Z)-nonenal standard; red: Δpxa1&2-9LHP
strain; green: Δpxa1&2-pESC strain. Figure AF4 LC-MS qualification results of
representative peptide fragmentation spectrum of glucose-6-phosphate
isomerase. Table AF1 Heat map of proteomics results in Table.
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